I believe publishing papers and citations are those proxy metrics.
[0] https://sohl-dickstein.github.io/2022/11/06/strong-Goodhart....
Publish a PR that has the word "fix" in the description, get it approved, release it to prod... you are the hero, took action, will get promoted, etc.
When it turns out that the "fix" makes everything worse... well, that's everyone _else's_ problem, like whichever users run into that change blowing up, whoever is on support that day, whoever has to undo it.
The old... "concentrated benefits and diffuse costs" problem.
I think once you come to terms with this, you come out on the other side realizing that this is nothing new. The idealized version never existed. What's new is the scale and all the quantitative metrics regarding publication.
> Academic research was meant to be about breaking new ground, keeping to honesty and good scientific conduct, being clear and upfront about uncertainties, errors, and mistakes, and improving our common understanding of science, all the while training the new generation to follow these goals and principles.
This is a naive idealism. Research takes effort and someone has to pay. Sometimes this someone's may profess beliefs that they only want to sponsor unrestricted objective inquiry, but everyone has biases and in an iterated game, soft preferences will be gamed too. In other words, there's is always an effect of "the one who pays orders the song".
The one who pays wants results. He wants prestige through the sponsored project. He doesn't want the researcher to just sit in a room and fail to generate results for years. He wants the researcher to have groundbreaking results. What they are matters less than that they be impressive and improve prestige of the funding source, among peers (in case of nobility funding it), or among the political classes (when government funds it), or to improve the PR and make the sponsor look good and charitable (if a company funds it as a sort of donation to academia).
Much of this "reward" that accrues to the funder does not really depend on the technical content of the work, only inasmuch as such quality was necessary to convince the research community to designate the work as impressive. However if this designation can be helped along via other paths, ie the quid pro quo and backscratching networks, that can be just as good for the funder as long as it doesn't rise to the level of fraud or something that may really damage the reputation.
Always,always follow the money and follow the chain of decisions.
Who will feel good at a cocktail party among their social peers when some impressive research result happens? Who can puff up their chest and say "We paid for that! Look how awesome we are!" and when they summarize the result in a soundbite will it impress their social peers?
This is not only applicable to the actual funding provider but also other orgs in the chain like university administration who provide facilities to the lab etc.
That is: the problems are in the system.
Better: if not plain fraud, the "faulty" papers should stay where they are, and editors (or conference chairs, etc.) should encourage follow-ups (incl. replications, commentaries, and whatever), which, with "modern" technology, could be linked to the papers.
What people typically do is just to ignore bad research, and withhold praise, and do their own research in a better direction.
A slightly sad side-effect of the follow-up-paper idea, is that it sometimes means that the authors get one more citation, and furthermore, since some of the authors may themselves write part of it, it would mean even more papers by the authors, potentially further cited. So we may be unfortunately incentivizing sloppy research -- the authors can now make two papers: one sloppy, and one fixed. Not sure that's great.
I am not saying what you are proposing is wrong. But it has side-effects that are not great.